This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Aoxing Pharmaceutical Co Inc (AXN)

: Health Care

Company Cash Flow
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Cash Flow From Operating Activities
Net Income (Loss) 5.49M -8.22M -16.80M 0.00
Operating Gains/Losses 93.35K 104.72K -371.64K 132.31K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.74M -1.93M -54.66K -764.16K
(Increase) Decrease in Inventories -1.02M 440.38K -770.53K -281.38K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 1.35M 454.77K 584.46K 39.70K
(Decrease) Increase In Other Current Liabilities 4.70M 4.86K 725.58K 401.13K
(Increase) Decrease In Other Working Capital 0.00 0.00 359.79K 0.00
Other Non-Cash Items 281.12K 496.34K 8.05M -1.86M
Net Cash From Continuing Operations 3.03M -7.73M -8.32M -1.33M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 3.03M -7.73M -8.32M -1.33M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -2.71M -268.92K -439.35K -752.39K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -2.71M -268.92K -439.35K -752.39K
Issuance of Debt 14.05M 11.33M 10.35M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 2.42M 0.00 0.00 0.00
Repayment of Long-Term Debt 0.00 -8.54M -796.00K 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -13.80M 3.52M -560.43K 2.82M
Net Cash From Financing Activities 2.67M 6.31M 8.99M 2.82M
Effect of Exchange Rate Changes 48.56K 7.65K 90.03K 169.22K
Net Change in Cash & Cash Equivalents 3.04M -1.68M 325.08K 912.00K
AXN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

AXN Aoxing Pharmaceutical Co Inc

Chart of AXN

Analysts Ratings for AXN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

AXN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs